Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Rodvold

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|August 15, 2018
Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infectionRodrigo M Burgos, Mark J Biagi, Keith A Rodvold, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2012
Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjectsGurudatt Chandorkar, Jennifer A Huntington, Mark H Gotfried, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2025
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participantsKeith A Rodvold, Mark H Gotfried, Philip Sabato, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 2005
Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administrationKelly A Sprandel, Diane E Styrczula, Kelly Deyo, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjectsKeith A Rodvold, Mark H Gotfried, J Gordon Still, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2009
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patientsThomas P Lodise, Nimish Patel, Ben M Lomaestro, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Robin D Isaacs, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationThomas P Lodise, Ben Lomaestro, Keith A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Pharmacotherapy|May 28, 2004
Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1Manjunath P Pai, Christopher A Schriever, Mariela Diaz-Linares, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Expert Opinion on Drug Metabolism & Toxicology|August 15, 2018
Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infectionRodrigo M Burgos, Mark J Biagi, Keith A Rodvold, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2012
Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjectsGurudatt Chandorkar, Jennifer A Huntington, Mark H Gotfried, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2025
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participantsKeith A Rodvold, Mark H Gotfried, Philip Sabato, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 2005
Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administrationKelly A Sprandel, Diane E Styrczula, Kelly Deyo, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjectsKeith A Rodvold, Mark H Gotfried, J Gordon Still, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2009
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patientsThomas P Lodise, Nimish Patel, Ben M Lomaestro, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Robin D Isaacs, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulationThomas P Lodise, Ben Lomaestro, Keith A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Pharmacotherapy|May 28, 2004
Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1Manjunath P Pai, Christopher A Schriever, Mariela Diaz-Linares, et al.
Pageof 11